Board of Directors

Providing vision and guidance to Gateway's mission is a robust group of individuals who have achieved success in their own fields. From banking to research to hospital management to foundations, the Board of Directors help Gateway set strategic priorities that are aligned with a diverse set of patient interests and needs.

Richard J Stephenson - Chairman
Chairman of the Board, Cancer Treatment Centers of America

Stacie J. Stephenson - Vice Chair
Chair, Functional Medicine, Cancer Treatment Centers of America

Tony Festa - Treasurer
Managing Principal & COO, Fund Evaluation Group, LLC

Fred DeGrandis - Secretary
President and CEO NorthCoast Healthcare Services, LLC

Amy Belew - Director
Head of Data and Business Intelligence - Individual Investors Group, T. Rowe Price

Tawnya Bond - Director
Principle Consultant, Bond Global Supply Chain Solutions

Michael Burton - Ex-Officio
President & CEO, Gateway for Cancer Research

Joe Caltabiano - Director
CEO and Director, Consolidated Choice Corp.

Jake Goldstein - Director
Managing Director IL Corporate Banking, CIBC

Emanuel Petricoin, PhD - Director
Co-Director, Center for Applied Proteomics and Molecular Medicine

Deniz Razon - Director
Head of U.S. Commercial, Servier Pharmaceuticals, LLC

Edwin Roberson - Director
Chief Executive Officer (Retired), Christ Community Health Services

Mary Lou Smith - Director
Co-Founder, Research Advocacy Network

Satish Tadikonda - Director
Managing Partner, Avigo Solutions

Fund One Day

It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial.

Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniverary, birthday, wedding, bar/bat mitzvah or graduation.